Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (SHA:603707)

China flag China · Delayed Price · Currency is CNY
9.67
+0.39 (4.20%)
Feb 3, 2026, 2:45 PM CST
-28.42%
Market Cap14.99B -25.3%
Revenue (ttm)3.76B -3.0%
Net Income649.83M
EPS0.40
Shares Out1.62B
PE Ratio23.10
Forward PE14.73
Dividend0.10 (1.06%)
Ex-Dividend DateJun 5, 2025
Volume19,688,071
Average Volume11,917,725
Open9.31
Previous Close9.28
Day's Range9.30 - 9.75
52-Week Range9.00 - 14.86
Beta0.69
RSI40.84
Earnings DateApr 30, 2026

About SHA:603707

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of drugs and APIs in China. It also provides heparin sodium, enoxaparin sodium, dalteparin sodium, nadroparin calcium, atracurium besylate, cisatracurium, calcium folinate, doxorubicin, milrinone, bleomycin, carboplatin, cytarabine, topotecan hydrochloride, phenylephrine hydrochloride, ganirelix acetate, furosemide, glycopyrrolate, neostigmine methylsulfate, succinylcholine chloride, reganosin, isoflurane blue, clofarabine, halo... [Read more]

Sector Healthcare
Founded 2000
Employees 1,360
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603707
Full Company Profile

Financial Performance

Financial Statements